Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $111.46 on CVS Health Corporation (NYSE:CVS) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $5.86 for the next fiscal and $N/A for underway quarter.
Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of CVS Health Corporation (NYSE:CVS) stands at 22.42.
Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For CVS Health Corporation Common S, the PEG ratio for coming 3-5 years is 1.14.
The technical analysis highlights that CVS Health Corporation Common S current is trading $1.04 points away or +1.08% from its 50-day moving average of $96.43. Further it is trading $-1.07 or -1.08% away its 200-day moving average of $98.54.
The 52-week high of CVS Health Corporation (NYSE:CVS) was $106.67 while lowest point recorded in 52-week was $86.50. It implies if stock price makes a movement of over $-9.20, it will record a new 52-week high. In the case of +12.68% drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know